Infanrix hexa vaccine recall

Vaccinations Equal Sterilizations

Via: pharmacynews
 Health professionals and consumers are advised that, after consultation with the TGA, six batches of Infanrix hexa (AUST R 132881) have been recalled by the sponsor, GlaxoSmithKline Australia (GSK). Infanrix hexa is a vaccine used to prevent six diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis (polio) and Haemophilus influenzae type b (Hib). It is given to children as part of the National Immunisation Program (NIP) and may be given to young children under the age of 8 years who have not been previously vaccinated. This precautionary recall is being taken because a surface in the area where one of the manufacturing steps for the vaccine takes place was found to have a small amount of contamination with the bacterium Bacillus cereus
Vaccine Exemption Forms